Mouwasat Medical Services Company

SASE:4002 Rapporto sulle azioni

Cap. di mercato: ر.س17.6b

Mouwasat Medical Services Crescita futura

Future criteri di controllo 3/6

Mouwasat Medical Services prevede che gli utili e i ricavi cresceranno rispettivamente di 13% e 10.9% all'anno. Si prevede che l'EPS crescerà di 13.7% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 21.7% in 3 anni.

Informazioni chiave

13.0%

Tasso di crescita degli utili

13.7%

Tasso di crescita dell'EPS

Healthcare crescita degli utili14.8%
Tasso di crescita dei ricavi10.9%
Rendimento futuro del capitale proprio21.7%
Copertura analitica

Good

Ultimo aggiornamento22 Jan 2025

Aggiornamenti recenti sulla crescita futura

Recent updates

The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Dec 12
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?

Sep 30
Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?

The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Sep 12
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Aug 06
Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Jul 01
Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Apr 23
Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today

Mar 18
Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today

Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement

Jan 23
Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement

Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors

Dec 17
Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors

Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger

Oct 05
Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger

Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?

Sep 17
Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?

The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Jul 03
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?

Jun 12
Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?

Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

Feb 24
Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price

Jan 18
Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price

Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing

Nov 24
Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing

Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

Aug 24
Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Jul 01
A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook

May 23
Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook

Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75

Apr 29
Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75

Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75

Apr 15
Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75

Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist

Mar 17
Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist

Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Mar 02
Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late

Feb 15
If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late

The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising

Dec 06
The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising

Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?

Nov 16
Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?

Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital

Aug 29
Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital

Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Aug 12
Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 29
Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value

Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher

May 26
Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher

Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

May 11
Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?

Apr 13
Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?

Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Mar 16
Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?

Mar 02
Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?

Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?

Feb 13
Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?

Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock

Feb 01
Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock

What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?

Jan 17
What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?

What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?

Jan 04
What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?

Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment

Dec 21
Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment

Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Dec 08
Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Nov 24
Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Previsioni di crescita degli utili e dei ricavi

SASE:4002 - Stime future degli analisti e dati finanziari passati (SAR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20274,0741,0169551,2253
12/31/20263,9248998851,11810
12/31/20253,41177261695210
12/31/20242,9346676241,1108
9/30/20242,897658542958N/A
6/30/20242,827665484874N/A
3/31/20242,764663521867N/A
12/31/20232,706658527814N/A
9/30/20232,5936598331,034N/A
6/30/20232,501625779970N/A
3/31/20232,431616517779N/A
12/31/20222,334599409707N/A
9/30/20222,226561213572N/A
6/30/20222,208581162542N/A
3/31/20222,177581313642N/A
12/31/20212,144578353683N/A
9/30/20212,125574342657N/A
6/30/20212,143593368643N/A
3/31/20212,085567287537N/A
12/31/20202,045528247481N/A
9/30/20202,016515258529N/A
6/30/20201,911447238520N/A
3/31/20201,889422255533N/A
12/31/20191,857421371635N/A
9/30/20191,808376339548N/A
6/30/20191,769364301548N/A
3/31/20191,717361202509N/A
12/31/20181,67736074386N/A
9/30/20181,652373-2364N/A
6/30/20181,608369N/A446N/A
3/31/20181,567358N/A462N/A
12/31/20171,507337N/A452N/A
9/30/20171,435314N/A462N/A
6/30/20171,356286N/A414N/A
3/31/20171,303274N/A336N/A
12/31/20161,243257N/A306N/A
9/30/20161,144235N/A190N/A
6/30/20161,095229N/A130N/A
3/31/20161,050221N/A173N/A
12/31/20151,000209N/A207N/A
9/30/2015926206N/A271N/A
6/30/2015925235N/A306N/A
3/31/2015914238N/A301N/A
12/31/2014904240N/A286N/A
9/30/2014961240N/A268N/A
6/30/2014942212N/A267N/A
3/31/2014927207N/A281N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 4002 ( 13% all'anno) è inferiore al tasso di risparmio ( 14.7% ).

Guadagni vs Mercato: Si prevede che gli utili di 4002 ( 13% all'anno) cresceranno più rapidamente del mercato SA ( 5.9% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 4002 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 4002 ( 10.9% all'anno) crescerà più rapidamente del mercato SA ( -0.5% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 4002 ( 10.9% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 4002 sarà elevato tra 3 anni ( 21.7 %)

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2025/02/07 09:32
Prezzo dell'azione a fine giornata2025/02/06 00:00
Guadagni2024/09/30
Guadagni annuali2023/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Mouwasat Medical Services Company è coperta da 22 analisti. 10 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Jassim Al-JubranAljazira Capital Company
Rim Ben Salah GharbiAlphaMena
Kais KriaaAlphaMena